Company Information

  

Address: 14 EINSTEIN ST.  
City: NES-ZIONA 
State:  
Zip Code: 74036 
Telephone: 972-8-9302529 

Description of Business

Primary SIC Code: 2836
(As filed with the SEC)  

Our legal commercial name is BiondVax Pharmaceuticals Ltd. We are a company limited by shares organized under the laws of Israel. We were incorporated in Israel in 2003 as a privately held company. In February 2007, we completed an initial public offering of our ordinary shares on the TASE, however, we voluntarily delisted from TASE as of January 22, 2018. In May 2015, we completed an initial public offering of our ADSs and ADS Warrants on the Nasdaq Capital Market. Our principal executive offices are located at 14 Einstein Street, Ness Ziona, Israel,7414002, and our telephone number is (+972) (8) 930-2529. Our agent for service of process in the United States is Puglisi & Associates, whose address is 850 Library Avenue, Suite 204, Newark, Delaware, and whose telephone number is (302) 738-6680.  ... More ...  

Per Share Overview

Date 12-mos Rolling EPS Dividend P/E Ratio
There's no share overview data.

Key Financial Ratios and Statistics

FYE: 12/31

Profitability 2017 Leverage 2017
Net Inc/Comm Equity-0.19Total Liab/Total Assets0.31
Net Inc/Total Assets-0.42Total Liab/Inv Cap0.34
Net Inc/Inv Cap-0.47Total Liab/Comm Equity0.14
Pretax Inc/Net SalesNAInterest Coverage Ratio-2.17
Net Inc/Net SalesNACurr Debt/Equity0.01
Cash Flow/Net SalesNALTD/Equity0.15
SG&A/NetSalesNATotal Debt/Equity0.16
Asset Utilization   Liquidity  
Net Receivables TurnoverNAQuick Ratio10.94
Inventory TurnoverNACurrent Ratio10.94
Inventory Day SalesNANet Rec/Curr Assets0.05
Net Sales/Work CapNAInv/Curr AssetsNA
Net Sales/PP&ENA  

Income Statement (Millions)

  12/31/2017 12/31/2016 12/31/2015 12/31/2014
Total Revenues(Net Sales) NA NA NA NA
Cost of Goods Sold NA NA NA NA
Selling & Admin Exps 1.41 1.07 0.87 0.68
Operating Income -6.81 -3.09 -2.91 -2.09
Interest Exp 3.14 0.08 0.01 0.00
Pretax Income -9.95 -2.39 -2.62 -2.00
Other Income 0.01 0.78 0.29 0.10
Net Income Bef Extraordinary ... NA NA NA NA
Net Income -9.95 -2.39 -2.62 -2.00

Balance Sheet (Millions)

Assets 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Cash & Short Term Investments 20.56 4.61 9.12 2.99
Receivables - Total 1.13 0.21 0.37 0.28
Inventories - Total NA NA NA NA
Total Current Assets 21.69 6.79 9.49 3.27
Net Property, Plant & Equipment 1.59 0.38 0.53 0.68
Total Assets 23.53 7.82 10.62 4.74
Liabilities        
Accounts Payable 1.79 0.18 0.24 0.14
Debt in Current Liabilities 0.19 0.18 0.20 0.33
Total Current Liabilities 1.98 0.36 0.44 0.47
Long-Term Debt 2.36 0.79 1.54 0.00
Total Liabilities 7.33 1.17 2.00 0.48
Stockholder's Equity        
Minority Interest NA NA NA NA
Preferred Stock NA NA NA NA
Common Stock 0.00 0.00 0.00 0.00
Retained Earnings -35.55 -23.09 -20.48 -17.86
Treasury Stock NA NA NA NA
Total Stockholders' Equity 16.20 6.66 8.62 4.26
Total Liabilities and Stockholders' Equity 23.53 7.82 10.62 4.74

Cash Flow Summary (Millions)

Categories 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Net Cash Provided by Operating Activities -2.90 -2.51 -2.64 -1.95
Net Cash Provided by Investing Activities 1.95 -2.03 -0.01 -0.05
Net Cash Provided by Financing Activities 17.81 0.00 8.68 -0.20

Annual Summary Data (Millions)

Year Sales Net Income EPS
12/20130.00-2.32--
12/20140.00-2.00--
12/20150.00-2.62--
12/20160.00-2.39--
12/20170.00-9.95--
Growth RatesNaN----

Stock Ownership

Type Date(Q,M) No. Owners Shares Held (000s) % Own
Institutional06/30/18384--




Report Date : 7/16/2018

Powered By Edgar Online © 2018EDGAR®Online, a division of Donnelley Financial Solutions. EDGAR® is a federally registered trademark of the U.S. Securities and Exchange Commission. EDGAR Online is not affiliated with or approved by the U.S. Securities and Exchange Commission.